Robin L. Washington
2014
In 2014, Robin L. Washington earned a total compensation of $6.2M as Executive Vice President and Chief Financial Officer at Gilead Sciences, a 58% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $965,250 |
|---|---|
| Option Awards | $1,947,382 |
| Salary | $797,601 |
| Stock Awards | $2,504,439 |
| Other | $8,820 |
| Total | $6,223,491 |
Washington received $2.5M in stock awards, accounting for 40% of the total pay in 2014.
Washington also received $965.3K in non-equity incentive plan, $1.9M in option awards, $797.6K in salary and $8.8K in other compensation.
Rankings
In 2014, Robin L. Washington's compensation ranked 1,141st out of 13,032 executives tracked by ExecPay. In other words, Washington earned more than 91.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,141 out of 13,032 | 91st |
Division Manufacturing | 420 out of 4,965 | 92nd |
Major group Chemicals And Allied Products | 138 out of 1,690 | 92nd |
Industry group Drugs | 108 out of 1,369 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 11 out of 241 | 95th |
Source: SEC filing on March 28, 2016.
Washington's colleagues
We found four more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2014.